-
1دورية أكاديمية
المصدر: Cancer Management and Research, Vol Volume 12, Pp 11541-11551 (2020)
مصطلحات موضوعية: nasopharyngeal carcinoma, c-reactive protein/albumin ratio, high-sensitivity c-reactive protein/albumin ratio, c-reactive protein/lymphocyte ratio, high-sensitivity c-reactive protein/lymphocyte ratio, survival, toxicity., Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Huang YF; The First Clinical College, Shanxi Medical University, Jinzhong, China., Zhang WM; Department of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China., Wei ZS; Department of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China., Huang H; Department of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China., Mo QY; Department of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China., Shi DL; Department of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China., Han L; Department of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China., Han YY; Department of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China., Nong SK; Department of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China., Lin GX; Department of Oncology, Wuming Hospital of Guangxi Medical University, Nanning, China.
المصدر: Frontiers in immunology [Front Immunol] 2023 Mar 09; Vol. 14, pp. 1136169. Date of Electronic Publication: 2023 Mar 09 (Print Publication: 2023).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
-
3دورية أكاديمية
المؤلفون: Liang ZG; Department of Radiation Oncology, The Affiliated Tumour Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, 71 He Di Road, Nanning 530021, P.R. China., Chen XQ; Department of Radiation Oncology, The Affiliated Tumour Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, 71 He Di Road, Nanning 530021, P.R. China., Lin GX; Department of Radiation Oncology, The Affiliated Tumour Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, 71 He Di Road, Nanning 530021, P.R. China., Yu BB; Department of Radiation Oncology, The Affiliated Tumour Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, 71 He Di Road, Nanning 530021, P.R. China., Chen KH; Department of Radiation Oncology, The Affiliated Tumour Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, 71 He Di Road, Nanning 530021, P.R. China., Zhong QL; Department of Radiation Oncology, The Affiliated Tumour Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, 71 He Di Road, Nanning 530021, P.R. China., Nong SK; Department of Radiation Oncology, The Affiliated Tumour Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, 71 He Di Road, Nanning 530021, P.R. China., Li L; Department of Radiation Oncology, The Affiliated Tumour Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, 71 He Di Road, Nanning 530021, P.R. China., Qu S; Department of Radiation Oncology, The Affiliated Tumour Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, 71 He Di Road, Nanning 530021, P.R. China., Su F; Department of Radiation Oncology, The Affiliated Tumour Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, 71 He Di Road, Nanning 530021, P.R. China., Zhao W; Department of Radiation Oncology, The Affiliated Tumour Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, 71 He Di Road, Nanning 530021, P.R. China., Li Y; Department of Radiation Oncology, The Affiliated Tumour Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, 71 He Di Road, Nanning 530021, P.R. China., Zhu XD; Department of Radiation Oncology, The Affiliated Tumour Hospital of Guangxi Medical University, Cancer Institute of Guangxi Zhuang Autonomous Region, 71 He Di Road, Nanning 530021, P.R. China.
المصدر: Scientific reports [Sci Rep] 2017 Feb 02; Vol. 7, pp. 41449. Date of Electronic Publication: 2017 Feb 02.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
مواضيع طبية MeSH: Chemoradiotherapy*, Carcinoma/*pathology , Carcinoma/*therapy , Nasopharyngeal Neoplasms/*pathology , Nasopharyngeal Neoplasms/*therapy, Adult ; Chemotherapy, Adjuvant ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Nasopharyngeal Carcinoma ; Neoplasm Staging ; ROC Curve ; Risk Factors ; Survival Analysis